Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
LG Chem will receive totaling up to $95.5 million for the China rights
This partnership stemmed from a successful customer-supplier relationship spanning several years.
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
They also released the Operational Guidelines for Wellness activities at AB-HWCs
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
Company to open new headquarters in 2024
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
These satellite institutes will further strengthen the research, international collaborations and facilitate affordable Ayush services for the larger community.
Subscribe To Our Newsletter & Stay Updated
